MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    A New Complex dystonic presentation of a rare gene – CACNA1B and its response to Levodopa

    S. Medarametla, B. Nataraju, S. Kodapala, S. Raju (Bangalore, India)

    Objective: We report a case of complex dystonia with the rare gene- CACNA1B. Background: CACNA1B gene has previously been reported as the cause of myoclonus-…
  • MDS Virtual Congress 2020

    Neural bases of dystonia penetrance and manifestation

    S. Khosravani, G. Chen, K. Simonyan (Boston, MA, USA)

    Objective: To identify functional and structural brain organization relevant to disease penetrance and clinical manifestation in patients with familial laryngeal dystonia (LD) and their unaffected…
  • MDS Virtual Congress 2020

    Clinical and etiological aspects of movement disorders in a low-income country: Case of Mali

    A. Bocoum, S.H Diallo, S. Diallo, A. Koita, Y. Maiga (Bamako, Mali)

    Objective: Describing Clinical and etiological aspects of movement disorders in Mali Background: Movement disorders (MD) correspond to a disturbance in the programming and / or…
  • MDS Virtual Congress 2020

    The incidence, predictors, and outcomes of delirium in Parkinson’s disease and atypical parkinsonism

    S. Green, A. McCleary, I. Sleeman, J. Maple-Grødem, C. Counsell, A. Macleod (Aberdeen, United Kingdom)

    Objective: To explore (i) the incidence of, (ii) the risk factors for, and (iii) the outcomes after, the first hospital episode of delirium in both…
  • MDS Virtual Congress 2020

    Measuring Unmet Need in Underserved Parkinson’s Populations (UPPs)

    S. Rosenfeld, M. Feeney, V. Todaro, A. Willis (New York, NY, USA)

    Objective: To identify health care needs and barriers among people with Parkinson's disease who are underserved so as to inform strategies to better serve this…
  • MDS Virtual Congress 2020

    Movement disorders associated with expansions and intermediate repeats in the C9orf72 gene

    C. Estevez-Fraga, F. Magrinelli, A. Latorre, S. Tabrizi, H. Houlden, K. Bhatia (London, United Kingdom)

    Objective: This work sought to investigate the frequency and characteristics of movement disorders (MD) associated with repeat expansions or intermediate repeats in the C9orf72 gene.…
  • MDS Virtual Congress 2020

    Genetic analysis of Huntington’s Disease in a Brazilian Amazonian population

    D. Brito, M. Della Coletta, G. Ferreira, L. Amorim, S. Souza, S. Peixoto, C. Rezende (Manaus, Brazil)

    Objective: Characterize genetically a series of cases of patients with Huntington’s disease and their family members at risk in the city of Manaus, capital of…
  • MDS Virtual Congress 2020

    Cytokines and Brain Specific Antibodies in Experimental Cellular and Molecular Treatment of Huntington’s Diseases

    D. Labunskiy, S. Kiryukhina, V. Podsevatkin (Saransk, Russian Federation)

    Objective: Huntington’s Disease (HD) is a severe neurodegenerative disorder main pathogenic factor is CAG repeats in a suffered patients genome. Experimental therapy on the model…
  • MDS Virtual Congress 2020

    A Novel Case of Persistent Segmental Spinal Myoclonus Due to Spinal Astrocytoma Temporarily Relieved by Diversion of Cerebrovascular Fluid

    Y. Huang, A. Chuang (Taoyuan, Taiwan)

    Objective: A 36-years-old woman with a spinal cord diffuse intramedullary astrocytoma WHO grade II, with multifocal brain parenchymal involvement. After insertion of her ventriculo-peritoneal shunt…
  • MDS Virtual Congress 2020

    Progressive supranuclear palsy: Common metabolic pattern in different variants

    G. Martí-Andrés, L. Van Bommel, S. Meles, M. Riverol, R. Valentí, R.V Kogan, R.J Renken, V. Gurvits, T. Van Laar, M. Pagani, E. Prieto, M.R Luquin, K.L Leenders, J. Arbizu (Pamplona, Spain)

    Objective: To define and cross-validate the brain glucose metabolic abnormalities in patients with a diagnosis of different PSP variants. Background: It remains unclear whether the supportive…
  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley